B&G Foods (BGS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Q1 2025 net sales declined 10.5% year-over-year to $425.4 million, driven by lower volumes, net pricing, product mix, negative foreign currency impact, and retailer inventory reductions.
Adjusted EBITDA fell 21.2% to $59.1 million, mainly due to lower sales, higher costs, and gross profit declines.
Net income was $0.8 million, reversing a net loss of $40.2 million in Q1 2024, which included a $70.6 million goodwill impairment.
Portfolio reshaping, cost reduction, and divestitures of non-core and frozen vegetable businesses remain top priorities.
Management noted stabilizing sales trends in March, April, and early May, despite industry headwinds.
Financial highlights
Q1 2025 net sales: $425.4 million, down $49.8 million (10.5%) from Q1 2024.
Adjusted EBITDA: $59.1 million (13.9% of net sales), down from $75 million (15.8%) in Q1 2024.
Adjusted net income: $3.4 million ($0.04 per share) vs. $14.4 million ($0.18 per share) in Q1 2024.
Gross profit: $90.1 million (21.2% of net sales); adjusted gross profit: $90.6 million (21.3%).
Net cash from operations: $52.7 million in Q1 2025 vs. $35.1 million in Q1 2024.
Outlook and guidance
FY 2025 net sales guidance revised to $1.86–$1.91 billion; adjusted EBITDA to $280–$290 million.
Adjusted EPS guidance: $0.55–$0.65.
Cost reduction plan expected to deliver $10 million in savings in 2025, with a $15–$20 million annual run rate.
Guidance excludes potential impacts from new or retaliatory tariffs and related trade actions.
Management expects certain raw material and freight costs to remain elevated for the remainder of 2025.
Latest events from B&G Foods
- Portfolio transformation and divestitures drive margin gains and lower leverage for 2026.BGS
Q4 20253 Mar 2026 - Q2 sales fell 5.3%, goodwill impairment hit results, and guidance was revised lower.BGS
Q2 20242 Feb 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 sales and EBITDA declined, but net income turned positive; outlook remains cautious.BGS
Q3 202416 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Sequential improvement, strong spices growth, and major impairments shape 2025 outlook.BGS
Q4 202418 Dec 2025 - Shelf registration allows up to $800M in securities for growth, debt, and acquisitions.BGS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for virtual shareholder vote.BGS
Proxy Filing1 Dec 2025